| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6177510 | European Urology | 2016 | 8 Pages |
Abstract
This retrospective study suggests that a combination of chemotherapy agents may extend survival compared with single-agent chemotherapy in selected patients with metastatic urothelial cancer progressing after prior chemotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Guru Sonpavde, Gregory R. Pond, Toni K. Choueiri, Stephanie Mullane, Guenter Niegisch, Peter Albers, Andrea Necchi, Giuseppe Di Lorenzo, Carlo Buonerba, Antonio Rozzi, Kazumasa Matsumoto, Jae-Lyun Lee, Hiroshi Kitamura, Haruki Kume, Joaquim Bellmunt,